Thursday, January 05, 2006

Cyborgs don't have to suffer from Dry Age Related Macular Degeneration

Neurotech Initiates a Phase II Clinical Trial of NT-501 for the Treatment of Dry Age Related Macular Degeneration: "NT-501 is an intraocular, polymer implant containing human retinal epithelial cells genetically modified to secrete Ciliary Neurotrophic Factor (CNTF). The implant is designed to continuously release CNTF directly in the eye to the diseased retinal tissue for sustained periods of time. The Phase II trial is a randomized, double-masked, sham-controlled dose ranging study that will evaluate the efficacy and safety of the CNTF implant and will be conducted at the National Eye Institute (NEI) in Bethesda, Maryland."


Blogger Bocaj said...

I've got a better one.

An Implantable Miniature Telescope from a Silicon Valley company that is implanted into the eye of the subjects to counteract macular degeneration. Bionic Vision! Passed clinical trail, and coming out this year.

Check out a link from my site to the story.

8:03 AM  

Post a Comment

<< Home